Table 2 Secondary effectiveness and implementation quantitative outcomes
Secondary outcomes | Sources | |
|---|---|---|
Effectiveness | • absolute difference in systolic and diastolic BP between baseline and 12-months visit • the proportion of participants who scored > 70% on the HDFQ | • Modified EHR, DCF |
Reach | • proportion of eligible PWH who agreed to be enrolled into InterCARE among those who met inclusion criteria | • Modified EHR, DCF |
Adoption | • proportion of PWH and HTN with 10-year CVD risk documented in EHR (E-CVDRF eval) • proportion with BP documented in EHR • proportion of those who received CVD risk factor counselling on anti-HTN medication, healthy diet and appropriate physical activity levels | • Modified EHR, DCF |
Fidelity | • proportion prescribed guideline concordant BP medication (as per Botswana 2017 Primary Care Guideline [27, 33] and/or major publication on management of BP among black Africans [34] • proportion of treatment partners trained per protocol • proportion providing support with the same frequency as expected | • DCF, electronic trial logs |
Exploratory secondary outcomes | ||
Fidelity/ Adoption | • proportion of participants with a treatment partner | • Modified EHR, DCF |